Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.32
-1.93%
Mkt Cap $430.34M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$12.00
Range $11.00 – $13.00
Implied Upside
+64.0%
Consensus $12.00 vs current $7.32